-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
Whole genome sequencing of colorectal cancer patients (SG-BULK-1)
Study
EGAS00001006030
-
Genomewide copy number alteration screening of circulating plasma DNA
Study
EGAS00001006031
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
The KATHERINE study of adjuvant trastuzumab emtansine in HER2-positive breast cancer: analysis of patients with HER2-negative residual invasive disease on re-testing
Study
EGAS00001006037
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-2)
Study
EGAS00001006039
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-3)
Study
EGAS00001006056
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059